| Genital Diseases, Male |
NCT01581749: Evaluation of Truebeam for Low-Intermediate Risk Prostate Cancer |
|
|
| Recruiting | 4 | 50 | US | "TrueBeam" stereotactic body radiosurgery | Albert DeNittis | Prostate Neoplasms | 12/17 | 12/22 | | |
| Active, not recruiting | 3 | 2205 | Europe, Canada, RoW | Prostatectomy, Conventionally Fractionated Prostate Radiotherapy, Prostate SBRT | Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Sutton, Surrey, UK | Prostate Cancer | 12/25 | 12/27 | | |
| Completed | 2 | 63 | RoW | Dendritic Cells DCVAC/PCa, Leuprolide acetate, Lupron, Goserelin Acetate, Zoladex | SOTIO a.s., Ascend Biopharmaceuticals Ltd | Basal Cell Carcinoma, Basal Cell Nevus Syndrome (BCNS) | 12/15 | 06/16 | | |
NCT00003915: Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer |
|
|
| Active, not recruiting | 2 | 63 | US | bicalutamide, docetaxel, estramustine phosphate sodium, leuprolide acetate | University of Massachusetts, Worcester | Prostate Cancer | 02/18 | 02/18 | | |
| Recruiting | 2 | 20 | RoW | Transperineal template guided mapping biopsy, multiparametric MRI, Hemiablative Focal Brachytherapy | St George Hospital, Australia | Prostate Cancer | 07/18 | 07/25 | | |
NCT02040610: Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer |
|
|
| Recruiting | 2 | 235 | US | Hypofractionated Proton Therapy, Proton Therapy | Provision Center for Proton Therapy, Center for Biomedical Research, LLC | Prostate Cancer | 12/19 | 12/25 | | |
FOKAL-BT, NCT02391051: Focal Brachytherapy in Patients With Selected "Low-risk" Prostate Cancer - a Phase-II-trial |
|
|
| Recruiting | 2 | 50 | Europe | HDR-Brachytherapy | University of Erlangen-Nürnberg Medical School | Prostate Cancer | 12/19 | 12/29 | | |
NCT01913106: HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer |
|
|
| Recruiting | 1/2 | 25 | US | HSV-tk +Valacyclovir in Combination with Brachytherapy, IND 13567 | The Methodist Hospital Research Institute | Prostatic Neoplasms | 12/18 | 12/28 | | |
NCT01516762: Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases |
|
|
| No Longer Available | N/A | | US | Radium-223 dichloride (BAY88-8223) | Bayer | Prostatic Neoplasms | | | | |
|
NCT02069652: Prevention of Transmission of Sexually Transmitted Diseases in the Youth Through Effective Intervention, |
|
|
| No Longer Available | N/A | | RoW | Lifestyle Counseling | Kaohsiung Medical University Chung-Ho Memorial Hospital | HIV | 12/14 | | | |
NCT00975546: HIV-discordant Couple Intrauterine Insemination |
|
|
| No Longer Available | N/A | | US | Sperm washing and testing for HIV contamination, Intrauterine Insemination | University of Missouri-Columbia | Infertility, HIV Infections | | | | |
LLLT, NCT02764034: Effect of Low Level Laser Therapy on Endometrial Cells: An In Vitro Study |
|
|
| Available | N/A | | RoW | Low level Laser diode machine | Cairo University | Infertility | | | | |
NCT01777061: Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan |
|
|
| No Longer Available | N/A | | US | [11C]Acetate, carbon-11 acetate [[11C]acetate], sodium acetate [11C]Acetate injection | Wendell Yap, MD, University of Kansas Medical Center | Prostate Cancer | | | | |
NCT01834209: A Study of Abiraterone Acetate Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer |
|
|
| No Longer Available | N/A | | RoW | Abiraterone acetate, Prednisone or prednisolone | Janssen Research & Development, LLC | Prostate Neoplasms | | | | |
NCT02901392: Fundación IVO Registry for Patients Undergoing Sling or Artificial Urinary Sphincter After Prostate Cancer Treatment |
|
|
| Recruiting | N/A | 400 | Europe | AMS-800, ADVANCE/ADVANCEXP, VIRTUE, INVANCE | Fundación Instituto Valenciano de OncologÃa | Urinary Incontinence, Stress | 04/19 | 04/31 | | |
NCT02865330: Spanish Urological Association Registry of Patients on Active Surveillance |
|
|
| Recruiting | N/A | 946 | Europe | Registry | Fundación Instituto Valenciano de OncologÃa | Prostate Cancer | 06/19 | 07/34 | | |
NCT02186925: A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney. |
|
|
| Recruiting | N/A | 1000 | RoW | | Meir Medical Center | Kidney Cancer, Prostate Cancer, Bladder Cancer | 08/19 | 08/25 | | |
SUPER-PC-AS, NCT02971085: Seoul National University Prospectively Enrolled Registry for Prostate Cancer With Active Surveillance |
|
|
| Recruiting | N/A | 410 | RoW | Active surveillance | Seoul National University Hospital | Prostate Cancer | 01/22 | 01/27 | | |
NCT02741102: Uterine Transplant in Absolute Uterine Infertility (AUIF) |
|
|
| Not yet recruiting | N/A | 10 | US | Uterine Transplant | Brigham and Women's Hospital | Female Infertility | 06/22 | 01/23 | | |
| Recruiting | N/A | 354 | Europe | questionnaire administration, assessment of therapy complications, high-intensity focused ultrasound ablation, multiparametric magnetic resonance imaging, quality-of-life assessment, transperineal prostate biopsy, transrectal prostate biopsy | University College, London | Male Erectile Disorder, Prostate Cancer, Therapy-related Toxicity, Urinary Incontinence | 12/28 | 06/29 | | |
NCT02869594: Institut Paoli Calmettes Prostate Cancer Database |
|
|
| Recruiting | N/A | 10000 | Europe | Data collection | Institut Paoli-Calmettes | Prostatic Neoplasms | 01/30 | 12/30 | | |
NCT02588404: The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient |
|
|
| Not yet recruiting | N/A | 65 | Canada | LHRH therapy, Eligard, Lupron, Trelstar, and Zoladex | Sir Mortimer B. Davis - Jewish General Hospital | Prostate Cancer | 01/30 | | | |